PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'SSD Sperimentazione Animale, Istituto Nazionale Tumori Fondazione G. Pascale - IRCSS, Naples, Italy.\', \'Laboratory of Cellular and Molecular Cardiovascular Patho-Physiology, Department of Biology, Ecology and Earth Science, University of Calabria, Rende, Italy.\', \'Institute of Human Virology, Division of Infectious Agents and Cancer, University of Maryland School of Medicine, Baltimore, MD, United States.\', \'School of Specialization in Food Science, University of Rome \'Tor Vergata\', Rome, Italy.\', \'Section of Clinical Nutrition and Nutrigenomics, Department of Biomedicine and Prevention, University of Rome \'Tor Vergata\', Rome, Italy.\', \'National Institute for Cardiovascular Research (INRC), Bologna, Italy.\', \'Scientific Director, Istituto Nazionale Tumori Fondazione G. Pascale - IRCSS, Naples, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2020.02094
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 32973818
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32973818>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32973818>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all